<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Plasma <z:chebi fb="0" ids="17230">homocysteine</z:chebi> was assessed in <z:e sem="disease" ids="C0004943" disease_type="Disease or Syndrome" abbrv="">Behcet's disease</z:e> (BD) patients in order to determine the prevalence of <z:e sem="disease" ids="C0598608" disease_type="Disease or Syndrome" abbrv="">hyperhomocysteinaemia</z:e> in BD and to test its association with clinical manifestations of the disease </plain></SENT>
<SENT sid="1" pm="."><plain>The study included 59 patients with BD and 118 age- and sex-matched healthy subjects </plain></SENT>
<SENT sid="2" pm="."><plain>Plasma <z:chebi fb="0" ids="17230">homocysteine</z:chebi>, vitamin B(12) and <z:chebi fb="3" ids="37445">folate</z:chebi> were assessed by automated immunoassay methods </plain></SENT>
<SENT sid="3" pm="."><plain>Hyperhomo-cysteinaemia was defined as plasma <z:chebi fb="0" ids="17230">homocysteine</z:chebi> &gt;15 micromol/l </plain></SENT>
<SENT sid="4" pm="."><plain>Plasma <z:chebi fb="0" ids="17230">homocysteine</z:chebi> concentrations and the prevalence of <z:e sem="disease" ids="C0598608" disease_type="Disease or Syndrome" abbrv="">hyperhomocysteinaemia</z:e> were significantly higher in BD patients than in controls [median (5th-95th percentile), 11.3 (6.6-28.1) vs. 10.6 (6.6-17.1) micromol/l, and 25.4% vs. 9.3%, respectively] </plain></SENT>
<SENT sid="5" pm="."><plain>In BD patients, <z:e sem="disease" ids="C0598608" disease_type="Disease or Syndrome" abbrv="">hyperhomocysteinaemia</z:e> was related to male gender, disease severity and <z:hpo ids='HP_0000554'>uveitis</z:hpo> [odds ratio (OR), 5.32; 95% confidence interval (CI), 1.43-21.61; p = 0.008], but not to age, smoking, disease activity, <z:hpo ids='HP_0002625'>deep venous thrombosis</z:hpo>, <z:hpo ids='HP_0001369'>arthritis</z:hpo> or neurological involvement </plain></SENT>
<SENT sid="6" pm="."><plain>The association between <z:hpo ids='HP_0000554'>uveitis</z:hpo> and <z:e sem="disease" ids="C0598608" disease_type="Disease or Syndrome" abbrv="">hyperhomocysteinaemia</z:e> persisted (multi-adjusted OR, 7.46; 95% CI, 1.03-54.3; p = 0.05) after adjusting for gender, age, disease activity and duration, smoking, <z:hpo ids='HP_0002625'>deep venous thrombosis</z:hpo>, and serum concentrations of <z:chebi fb="0" ids="16737">creatinine</z:chebi>, vitamin B(12) and <z:chebi fb="3" ids="37445">folate</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>Plasma <z:chebi fb="0" ids="17230">homocysteine</z:chebi> should be measured in patients with BD, and the effect of B-vitamin supplementation should be tested in those with hyperhomo-cysteinaemia </plain></SENT>
</text></document>